| Date Filed | Type | Description |
| 08/08/2023 |
SC 13G/A
| BlackRock Inc. reports a 0% stake in DA32 Life Science Tech Acquisition Corp. |
| 08/04/2023 |
SC 13D/A
| ARCH Venture Fund XI, L.P. reports a 90.5% stake in DA32 Life Science Tech Acquisition Corp. |
| 08/02/2023 |
SC 13D/A
| Section 32 Fund 3, LP reports a 94.1% stake in DA32 Life Science Tech Acquisition Corp. |
| 08/01/2023 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 08/01/2023 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 07/28/2023 |
25-NSE
| Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities: |
| 07/21/2023 |
8-K
| Quarterly results |
| 05/15/2023 |
SC 13G/A
| RA CAPITAL MANAGEMENT, L.P. reports a 0% stake in DA32 Life Science Tech Acquisition Corp. |
| 05/12/2023 |
10-Q
| Quarterly Report for the period ended March 31, 2023 |
| 03/29/2023 |
10-K
| Annual Report for the period ended December 31, 2022 |
| 02/14/2023 |
SC 13G/A
| Saba Capital Management, L.P. reports a 6.1% stake in DA32 Life Science Tech Acquisition Corp |
| 02/06/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/06/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 01/31/2023 |
SC 13G/A
| BlackRock Inc. reports a 7.3% stake in DA32 Life Science Tech Acquisition Corp. |
| 08/15/2022 |
10-Q
| Quarterly Report for the period ended June 30, 2022 |
| 05/13/2022 |
10-Q
| Quarterly Report for the period ended March 31, 2022 |
| 03/31/2022 |
10-K
| Annual Report for the period ended December 31, 2021 |
| 02/10/2022 |
SC 13G/A
| WELLINGTON MANAGEMENT GROUP LLP reports a 0% stake in DA32 Life Science Tech Acquisition Corp. |
| 02/07/2022 |
SC 13G
| Saba Capital Management, L.P. reports a 5.4% stake in DA32 Life Science Tech Acquisition Corp |
| 02/02/2022 |
SC 13G
| VICTORY CAPITAL MANAGEMENT INC reports a 5.5% stake in DA32 Life Science Tech |
| 11/15/2021 |
10-Q
| Quarterly Report for the period ended September 30, 2021 |
| 08/10/2021 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 08/09/2021 |
SC 13D
| Form SC 13D - General statement of acquisition of beneficial ownership: |
| 08/09/2021 |
SC 13D
| Form SC 13D - General statement of acquisition of beneficial ownership: |
| 08/09/2021 |
SC 13D
| Form SC 13D - General statement of acquisition of beneficial ownership: |
| 08/09/2021 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 08/09/2021 |
SC 13D
| DA32 Sponsor LLC reports a 19.9% stake in DA32 Life Science Tech Acquisition Corp. |
| 08/09/2021 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 08/05/2021 |
8-K
| Quarterly results |
| 07/30/2021 |
8-K
| Quarterly results |
| 07/29/2021 |
424B4
| Form 424B4 - Prospectus [Rule 424(b)(4)]: |
| 07/28/2021 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 07/27/2021 |
CERT
| Form CERT - Certification by an exchange approving securities for listing: |
| 07/27/2021 |
8-A12B
| Form 8-A12B - Registration of securities [Section 12(b)]: |